K. Landmark et al., NITRENDIPINE AND MEFRUSIDE IN ELDERLY HYPERTENSIVES - EFFECTS ON BLOOD-PRESSURE, CARDIAC-OUTPUT, CEREBRAL BLOOD-FLOW AND METABOLIC PARAMETERS, Journal of human hypertension, 9(4), 1995, pp. 281-285
In this multicentre, randomised, double-blind, crossover study, we eva
luated and compared the effects of nitrendipine (a calcium entry block
er of the dihydropyridine group) and mefruside (a diuretic) on BP, car
diac output, cerebral blood flow and metabolic parameters in 22 elderl
y hypertensives. Eight weeks of treatment with nitrendipine (27.3 mg d
aily) and mefruside (30.7 mg daily) significantly reduced BP values to
almost the same extent. Heart rate, cardiac output (n = 14), cerebral
blood flow (n = 20), renin activity and aldosterone remained unchange
d during nitrendipine and mefruside treatment. Nitrendipine did not al
ter any metabolic parameter (electrolytes, lipid values and blood gluc
ose); in patients treated with mefruside serum potassium fell by 0.4 m
mol/l (P < 0.001). Minor adverse events were reported in both treatmen
t groups, mostly due to vasodilation. We conclude that both drugs poss
ess potent and comparable haemodynamic and anti-hypertensive propertie
s. They reduce BP by reducing total peripheral vascular resistance wit
h maintained autoregulation of cerebral blood flow. The metabolic dist
urbances induced by mefruside seem to be less pronounced than that obs
erved with other thiazide diuretics.